TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC)
TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC)
Active, not recruiting · NCT06082635 · Registry updated 2025-05-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 3 | 2025-05-18 | NCT06082635 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shenzhen TargetRx Co., Ltd. | 9 |
| Sun Yat-Sen University Cancer Center | 74 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sun Yat-sen University Cancer Center | Guangzhou | China | 315 |